Science | ABNewswire

AI Magazine Netherlands names IntraGPT most secure and best local AI LLM

IntraGPT gives organisations their own private AI environment that runs on Dutch servers and private infrastructure. Data stays within the Netherlands and is protected by strict national and European rules for privacy and security. Dutch local AI platform sets new … Continue reading →

Cannanda Launches CB2 Cool: The World’s Leading Beta-Caryophyllene Brand Expands with a Breakthrough Stress Relief Oil

Cannanda CB2 Cool is the latest beta-caryophyllene innovation from the brand that best known for creating “CB2 oils” Cannanda Launches CB2 Cool: The World’s Leading Beta-Caryophyllene Brand Expands with a Breakthrough Stress Relief Oil. With demand for beta-caryophyllene (BCP) at … Continue reading →

Allergic Rhinitis Market Size in the US was ~USD 3,600 million in 2023 and it is further expected to increase by 2034, estimates DelveInsight

DelveInsight’s “Allergic Rhinitis Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Allergic Rhinitis, historical and forecasted epidemiology as well as the Allergic Rhinitis market trends in the United States, EU4 (Germany, Spain, Italy, France) the … Continue reading →

Interstitial Lung Disease Market Size in the 7MM is projected to grow at a significant CAGR by 2032, estimates DelveInsight

DelveInsight’s “Interstitial Lung Disease Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Interstitial Lung Disease, historical and forecasted epidemiology as well as the Interstitial Lung Disease market trends in the United States, EU4 (Germany, Spain, … Continue reading →

Axial Spondyloarthritis Market Size in the 7MM is anticipated to grow with a significant CAGR by 2034, estimates DelveInsight

DelveInsight’s “Axial Spondyloarthritis Market Insights, Epidemiology and Market Forecast–2034” report delivers an in-depth understanding of the indication axial spondyloarthritis, historical and forecasted epidemiology as well as the axial spondyloarthritis market trends in the United States, EU4 (Germany, Spain, Italy, and … Continue reading →

Precision Meets Affordability, Ace Therapeutics Unveils In Vivo Efficacy Testing Services for IBD Drug Candidates

IBD Mouse Models Ace Therapeutics recently launched in vivo efficacy testing services for IBD drug candidates. Ace Therapeutics, a preclinical contract research provider, announced recently that it has launched in vivo efficacy testing services for IBD drug candidates. Building on in … Continue reading →

Asthma Clinical Trial Pipeline Gains Momentum: 80+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Asthma Pipeline Insight 2025” report provides comprehensive insights about 80+ companies and 90+ pipeline drugs in the Asthma pipeline landscape. It covers the Asthma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Asthma therapeutics … Continue reading →

Hepatitis B Virus Infection Clinical Trial Pipeline Accelerates as 80+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Hepatitis B Virus Infection Pipeline Insight 2025” report provides comprehensive insights about 80+ companies and 90+ pipeline drugs in Hepatitis B Virus (HBV) Infection pipeline landscape. It covers the Hepatitis B Virus Infection pipeline drug profiles, including clinical and … Continue reading →

Limited-Time Window Savings from Advanced Window Products

Advanced Window Products Advanced Window Products announced a limited-time promotion allowing homeowners to receive a fourth non-impact window free when purchasing three, with a minimum of 10 windows per project. The offer targets homeowners planning larger window upgrades and seeking … Continue reading →

Hiteck’s rhNGF Eye Drops (HT006.2.2) Demonstrate Favorable Safety in First-in-Human Study Published in EJPS

The study demonstrated favorable safety and tolerability across all dose groups in healthy volunteers, supporting the continued advancement of the drug’s clinical development for patients with neurotrophic keratitis (NK). Wuhan Hiteck Biopharmaceutical Co., Ltd. announced that results from the first-in-human … Continue reading →

Wednesday - January 07, 2026

Category Archives: Science